| Feb 13, 2025 |
Feb 14, 2025 |
NEUROCRINE BIOSCIENCES INC
|
Chief Medical Officer |
Sell |
38.8
|
-2,218
|
-2.08%
|
✓
|
$258.3K |
| Feb 8, 2025 |
Feb 12, 2025 |
NEUROCRINE BIOSCIENCES INC
|
Chief Medical Officer |
Sell |
41.3
|
-980
|
-2.86%
|
✓
|
$115.9K |
| Jan 31, 2025 |
Feb 4, 2025 |
NEUROCRINE BIOSCIENCES INC
|
Chief Medical Officer |
Sell |
37.5
|
-1,457
|
-4.31%
|
✓
|
$222.6K |
| Feb 13, 2024 |
Feb 15, 2024 |
NEUROCRINE BIOSCIENCES INC
|
Chief Medical Officer |
Sell |
37.5
|
-1,114
|
-4.49%
|
✓
|
$148.1K |
| Feb 6, 2024 |
Feb 8, 2024 |
NEUROCRINE BIOSCIENCES INC
|
Chief Medical Officer |
Sell |
35.0
|
-2,101
|
-4.50%
|
✓
|
$291K |
| Jan 31, 2024 |
Feb 2, 2024 |
NEUROCRINE BIOSCIENCES INC
|
Chief Medical Officer |
Sell |
32.5
|
-1,457
|
-6.54%
|
✓
|
$205.1K |
| Dec 22, 2023 |
Dec 27, 2023 |
NEUROCRINE BIOSCIENCES INC
|
Chief Medical Officer |
Sell |
5.0
|
-10,000
|
-33.87%
|
✓
|
$1.3M |
| Dec 12, 2023 |
Dec 14, 2023 |
NEUROCRINE BIOSCIENCES INC
|
Chief Medical Officer |
Sell |
15.0
|
-13,925
|
-19.08%
|
✓
|
$1.7M |
| Dec 7, 2023 |
Dec 11, 2023 |
NEUROCRINE BIOSCIENCES INC
|
Chief Medical Officer |
Sell |
3.8
|
-77,679
|
-30.49%
|
✓
|
$9.4M |
| Dec 6, 2023 |
Dec 8, 2023 |
NEUROCRINE BIOSCIENCES INC
|
Chief Medical Officer |
Sell |
10.0
|
-8,396
|
-22.14%
|
✓
|
$1M |
| Aug 21, 2023 |
Aug 23, 2023 |
NEUROCRINE BIOSCIENCES INC
|
Chief Medical Officer |
Sell |
26.3
|
-3,198
|
-9.77%
|
✓
|
$343.4K |
| Apr 24, 2023 |
Apr 26, 2023 |
NEUROCRINE BIOSCIENCES INC
|
Chief Medical Officer |
Sell |
5.0
|
-14,400
|
-35.08%
|
✓
|
$1.5M |
| Feb 6, 2023 |
Feb 8, 2023 |
NEUROCRINE BIOSCIENCES INC
|
Chief Medical Officer |
Sell |
20.0
|
-16,525
|
-10.77%
|
✓
|
$1.7M |
| Jan 31, 2023 |
Feb 2, 2023 |
NEUROCRINE BIOSCIENCES INC
|
Chief Medical Officer |
Sell |
32.5
|
-1,457
|
-5.27%
|
✓
|
$160.3K |
| Feb 7, 2022 |
Feb 9, 2022 |
NEUROCRINE BIOSCIENCES INC
|
Chief Medical Officer |
Sell |
35.0
|
-3,724
|
-4.98%
|
✓
|
$299.6K |
| Jan 10, 2022 |
Jan 12, 2022 |
NEUROCRINE BIOSCIENCES INC
|
Chief Medical Officer |
Sell |
25.0
|
-2,632
|
-11.01%
|
✓
|
$196.1K |
| Feb 8, 2021 |
Feb 9, 2021 |
NEUROCRINE BIOSCIENCES INC
|
Chief Medical Officer |
Sell |
30.0
|
-2,363
|
-6.17%
|
✓
|
$275.9K |
| Jan 8, 2021 |
Jan 12, 2021 |
NEUROCRINE BIOSCIENCES INC
|
Chief Medical Officer |
Sell |
22.5
|
-2,632
|
-14.24%
|
✓
|
$292.3K |
| Nov 12, 2020 |
Nov 16, 2020 |
NEUROCRINE BIOSCIENCES INC
|
Chief Medical Officer |
Sell |
25.0
|
-2,257
|
-14.34%
|
✓
|
$204.8K |
| Aug 5, 2020 |
Aug 7, 2020 |
NEUROCRINE BIOSCIENCES INC
|
Chief Medical Officer |
Sell |
17.5
|
-2,257
|
-16.47%
|
✓
|
$268.2K |
| Jun 23, 2020 |
Jun 25, 2020 |
NEUROCRINE BIOSCIENCES INC
|
Chief Medical Officer |
Sell |
7.5
|
-5,000
|
-34.68%
|
✓
|
$650K |
| Apr 24, 2020 |
Apr 28, 2020 |
NEUROCRINE BIOSCIENCES INC
|
Chief Medical Officer |
Sell |
20.0
|
-1,934
|
-17.04%
|
✓
|
$192.4K |
| Feb 7, 2020 |
Feb 11, 2020 |
NEUROCRINE BIOSCIENCES INC
|
Chief Medical Officer |
Sell |
20.0
|
-1,623
|
-17.88%
|
✓
|
$167.7K |
| Jan 8, 2020 |
Jan 10, 2020 |
NEUROCRINE BIOSCIENCES INC
|
Chief Medical Officer |
Sell |
7.5
|
-2,632
|
-30.52%
|
✓
|
$292.4K |
| Jan 8, 2019 |
Jan 10, 2019 |
NEUROCRINE BIOSCIENCES INC
|
Chief Medical Officer |
Sell |
10.0
|
-1,857
|
-37.14%
|
✓
|
$156.2K |